Hagström H G, Hahlin M, Sjöblom P, Lindblom B
Department of Obstetrics and Gynaecology, Sahlgrenska Hospital, University of Göteborg, Sweden.
Hum Reprod. 1994 Jun;9(6):1170-4. doi: 10.1093/oxfordjournals.humrep.a138653.
A total of 60 patients underwent injection of prostaglandin (PG)F2 alpha into the affected tube and corpus luteum. Two serum samples, with a mean interval of 2.1 days, were taken pre-operatively and human chorionic gonadotrophin (HCG) and progesterone were determined by fluoroimmunoassay retrospectively. Cases requiring a second intervention (n = 8) were compared with uncomplicated cases (n = 52). The receiver-operator characteristic curve was used to determine optimal discriminatory levels of each diagnostic test. Among the complicated cases, 75% had progesterone values > 20 nmol/l and 100% had a daily HCG increase > 50 IU/l. The corresponding figures for the uncomplicated cases were 17% and 23% respectively. A 'high-risk' group representing 12% of the patient material was identified, and was biochemically profiled by serum progesterone values > 20 nmol/l, together with daily HCG changes > +50 IU/l/day. These patients had an 86% risk for a second intervention. Conversely, 88% of patients had only a 4% risk for such an intervention. We conclude that the combined use of two sequential serum HCG samples and one serum progesterone sample, the last of each taken not more than 24 h pre-operatively, can predict the risk for a complicated course following local injection of 15-methyl-PGF2 alpha for small tubal pregnancies.
共有60例患者接受了将前列腺素(PG)F2α注射到患侧输卵管和黄体中的治疗。术前采集了两份血清样本,平均间隔时间为2.1天,术后通过荧光免疫测定法回顾性测定了人绒毛膜促性腺激素(HCG)和孕酮。将需要二次干预的病例(n = 8)与未出现并发症的病例(n = 52)进行了比较。采用受试者工作特征曲线来确定每种诊断测试的最佳鉴别水平。在出现并发症的病例中,75%的患者孕酮值>20 nmol/l,100%的患者HCG每日升高>50 IU/l。未出现并发症的病例的相应数字分别为17%和23%。确定了一个占患者总数12%的“高危”组,其生化特征为血清孕酮值>20 nmol/l,同时HCG每日变化>+50 IU/l/天。这些患者二次干预的风险为86%。相反,88%的患者二次干预的风险仅为4%。我们得出结论,术前最后一次采集的两份连续血清HCG样本和一份血清孕酮样本联合使用,且每份样本采集时间不超过术前24小时,可以预测局部注射15 - 甲基 - PGF2α治疗小输卵管妊娠后出现复杂病程的风险。